
Patent Law Weblog
recent posts
- Solicitor General Proves Persuasive; Supreme Court Grants Hikma’s Certiorari Petition
- CNIPA Implements Inventor ID Requirement
- Ethanol Boosting Systems, LLC v. Ford Motor Co. (Fed. Cir. 2025)
- Judge Newman’s Petition for Rehearing En Banc Denied
- USPTO Announces Issuance of One Millionth Electronic Patent
about
Category: Conferences & CLE’s
-
Technology Transfer Tactics will be offering a webinar entitled "The USPTO's Updated Guidance on Section 101: Adjusting Your IP Evaluations for Maximum Protection" on March 5, 2019 from 1:00 pm to 2:00 pm (ET). Tyson Benson of Harness, Dickey & Pierce, PLC will address adjustments that should be made to IP evaluations in light of…
-
Strafford will be offering a webinar entitled "New EU Guidelines for Patenting AI and Machine Learning Technologies: Comparison With U.S. Approach — Navigating EPO and USPTO Rules to Maximize Patent Protection" on February 26, 2019 from 1:00 to 2:30 pm (EST). Aliza G. Carrano and Susan Y. Tull of Finnegan Henderson Farabow Garrett & Dunner…
-
February 11, 2019 – "The Next Billion-Dollar Acquisition in Pharma — A Forward-Looking Patent Analysis on Bristol-Myers Squibb Acquiring Celgene" (LexisNexis) – 2:00 pm (ET) February 12, 2019 – "Biotech Patents and Section 101 Rejections: Meeting Patent Eligibility Requirements — Leveraging Recent Decisions and USPTO Guidance to Overcome Rejections" (Strafford) – 1:00 to 2:30 pm…
-
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar entitled "New Developments in Patent-Eligibility with a Focus on the Abstract Idea Exception" on February 20, 2019 from 10:00 am to 11:15 am (CT). In this presentation, MBHB attorney and Patent Docs author Michael Borella will provide an up-to-date overview of recent 35…
-
LexisNexis will be offering a webinar on "The Next Billion-Dollar Acquisition in Pharma — A Forward-Looking Patent Analysis on Bristol-Myers Squibb Acquiring Celgene" on February 11, 2019 at 2:00 pm (ET). Gene Quinn of IPWatchdog and Kevin Noonan of Patent Docs will take a look at the recently announced merger between Bristol-Myers Squibb and Celgene, including…
-
Strafford will be offering a webinar entitled "Section 112 Issues in IPR Proceedings: Using Section 112 as a Sword or a Shield — Addressing Section 112 Issues in IPR Petitions, Establishing Priority or Earlier Critical Date of Asserted Reference, and More" on February 14, 2019 from 1:00 to 2:30 pm (EST). Jonathan R. Bowser of…
-
Strafford will be offering a webinar entitled "Biotech Patents and Section 101 Rejections: Meeting Patent Eligibility Requirements — Leveraging Recent Decisions and USPTO Guidance to Overcome Rejections" on February 12, 2019 from 1:00 to 2:30 pm (EST). Amanda K. Murphy, Steven P. O'Connor, Sanya Sukduang, and Sara A. Leiman of Finnegan Henderson Farabow Garrett &…
-
Strafford will be offering a webinar entitled "Conducting and Analyzing Prior Art Searches — Strategies for Validity, Patentability, Infringement, FTO and State-of-the-Art Searches" on February 27, 2019 from 1:00 to 2:30 pm (EST). Thomas L. Irving and Christopher C. Johns of Finnegan Henderson Farabow Garrett & Dunner, Kim Jordahl of KSJLaw, and Stephanie Curcio of…
-
Strafford will be offering a webinar entitled "Infringement of IP Rights in Augmented and Virtual Reality — Protecting and Monitoring Trademarks, Right of Publicity, Copyrights" on February 21, 2019 from 1:00 to 2:30 pm (EST). J Alexia Bedat of Klaris Law, Kimberly Culp of Carr McClellan, and James G. Gatto of Sheppard Mullin Richter &…
-
January 22, 2019 – "Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation" (Strafford) – 1:00 to 2:30 pm (EST) January 22, 2019 – European patent prosecution & litigation webinars with focus on UK, Germany, and EPO & CJEU (D Young & Co) – 1:00 pm, 2:30 pm, and 3:30 pm…